HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 80 filers reported holding HARROW HEALTH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,720 | +0.6% | 11,254 | +33.3% | 0.00% | 0.0% |
| Q2 2023 | $160,793 | +185.4% | 8,445 | +217.1% | 0.00% | – |
| Q1 2023 | $56,349 | +1027.0% | 2,663 | +330.2% | 0.00% | – |
| Q2 2022 | $5,000 | -93.7% | 619 | -94.6% | 0.00% | – |
| Q4 2020 | $79,000 | +107.9% | 11,569 | +68.4% | 0.00% | – |
| Q3 2020 | $38,000 | -59.1% | 6,868 | -61.7% | 0.00% | – |
| Q2 2020 | $93,000 | -63.1% | 17,915 | -72.8% | 0.00% | -100.0% |
| Q1 2020 | $252,000 | -21.2% | 65,852 | +59.9% | 0.00% | 0.0% |
| Q4 2019 | $320,000 | -76.9% | 41,178 | -83.3% | 0.00% | -81.8% |
| Q3 2019 | $1,388,000 | +622.9% | 247,005 | +1017.3% | 0.01% | +450.0% |
| Q2 2019 | $192,000 | -45.3% | 22,108 | -68.6% | 0.00% | -50.0% |
| Q1 2019 | $351,000 | – | 70,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
| Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
| Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
| Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
| Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
| Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
| BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
| EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
| Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |